These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 1801635)

  • 1. In vitro and in vivo functional activities of monoclonal antibodies reactive with Pseudomonas aeruginosa serogroup 6 lipopolysaccharides.
    Pollack M; Tao M; Akiyama M; Pier GB; Koles NL
    Antibiot Chemother (1971); 1991; 44():163-71. PubMed ID: 1801635
    [No Abstract]   [Full Text] [Related]  

  • 2. Opsonic and protective activity of five human IgM monoclonal antibodies reactive with lipopolysaccharide antigen of Pseudomonas aeruginosa.
    Collins MS; Ladehoff DK; Mehton NS; Noonan JS
    FEMS Microbiol Immunol; 1990 Dec; 2(5-6):263-8. PubMed ID: 2127368
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Functionally active monoclonal antibody that recognizes an epitope on the O side chain of Pseudomonas aeruginosa immunotype-1 lipopolysaccharide.
    Stoll BJ; Pollack M; Young LS; Koles N; Gascon R; Pier GB
    Infect Immun; 1986 Sep; 53(3):656-62. PubMed ID: 2427453
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapy of established experimental Pseudomonas aeruginosa infections with oral ciprofloxacin and five human monoclonal antibodies against lipopolysaccharide antigens.
    Collins MS; Ladehoff D; Mehton NS
    Antibiot Chemother (1971); 1991; 44():185-95. PubMed ID: 1801636
    [No Abstract]   [Full Text] [Related]  

  • 5. Characterization of mouse monoclonal antibodies directed against Pseudomonas aeruginosa lipopolysaccharides.
    Sadoff JC; Wright DC; Futrovsky S; Sidberry H; Collins H; Kaufmann B
    Antibiot Chemother (1971); 1985; 36():134-46. PubMed ID: 3923911
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protection against infection with Pseudomonas aeruginosa by passive transfer of monoclonal antibodies to lipopolysaccharides and outer membrane proteins.
    Sawada S; Suzuki M; Kawamura T; Fujinaga S; Masuho Y; Tomibe K
    J Infect Dis; 1984 Oct; 150(4):570-6. PubMed ID: 6436393
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Specificity and function of murine monoclonal antibodies and immunization-induced human polyclonal antibodies to lipopolysaccharide subtypes of Pseudomonas aeruginosa serogroup 06.
    Pier GB; Koles NL; Meluleni G; Hatano K; Pollack M
    Infect Immun; 1994 Apr; 62(4):1137-43. PubMed ID: 8132318
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protective efficacy of Pseudomonas aeruginosa type-A flagellin in the murine burn wound model of infection.
    Faezi S; Safarloo M; Amirmozafari N; Nikokar I; Siadat SD; Holder IA; Mahdavi M
    APMIS; 2014 Feb; 122(2):115-27. PubMed ID: 23758581
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human monoclonal antibodies to Pseudomonas aeruginosa type-specific lipopolysaccharides, toxin A and Klebsiella capsular polysaccharides.
    Lang AB; Fürer E; Schürch U; Cross AS; Larrick JW; Cryz SJ
    Dev Biol Stand; 1990; 71():121-6. PubMed ID: 1698165
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of antibody response to Pseudomonas aeruginosa in patients with wound infections.
    Trafny EA; Grzybowski J; Patzer J; Popiel D; Wrembel-Wargocka J; Dzierzanowska D; Zawistowska-Marciniak I; Kobus K
    Microbiol Immunol; 1991; 35(6):435-42. PubMed ID: 1921760
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of monoclonal antibodies to protein F of Pseudomonas aeruginosa as opsonins for phagocytosis by macrophages.
    Battershill JL; Speert DP; Hancock RE
    Infect Immun; 1987 Oct; 55(10):2531-3. PubMed ID: 3115901
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protection against experimental Pseudomonas infection with O antigen-specific human monoclonal antibodies.
    Sawada S; Kawamura T; Masuho Y; Iyobe S; Hashimoto H
    Antibiot Chemother (1971); 1989; 42():210-7. PubMed ID: 2480743
    [No Abstract]   [Full Text] [Related]  

  • 13. Human monoclonal antibodies against Pseudomonas aeruginosa lipopolysaccharide derived from transgenic mice containing megabase human immunoglobulin loci are opsonic and protective against fatal pseudomonas sepsis.
    Hemachandra S; Kamboj K; Copfer J; Pier G; Green LL; Schreiber JR
    Infect Immun; 2001 Apr; 69(4):2223-9. PubMed ID: 11254577
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nonopsonic antibodies in cystic fibrosis. Pseudomonas aeruginosa lipopolysaccharide-specific immunoglobulin G antibodies from infected patient sera inhibit neutrophil oxidative responses.
    Eichler I; Joris L; Hsu YP; Van Wye J; Bram R; Moss R
    J Clin Invest; 1989 Dec; 84(6):1794-804. PubMed ID: 2512330
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibodies raised against divalent type b flagellin and pilin provide effective immunotherapy against Pseudomonas aeruginosa infection of mice with burn wounds.
    Saffari M; Behbood S; Irajian G; Khorshidi A; Moniri R; Behrouz B
    Biologicals; 2017 Jan; 45():20-26. PubMed ID: 27836582
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Isolation and characterization of a human monoclonal antibody that recognizes epitopes shared by Pseudomonas aeruginosa immunotype 1, 3, 4, and 6 lipopolysaccharides.
    Lang AB; Fürer E; Larrick JW; Cryz SJ
    Infect Immun; 1989 Dec; 57(12):3851-5. PubMed ID: 2509371
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Establishment of stable cell lines producing anti-Pseudomonas aeruginosa monoclonal antibodies and their protective effects for the infection in mice.
    O'Oka H; Chonan E; Mizutani K; Fukuda T; Kuroiwa Y; Ono Y; Shigeta S
    Microbiol Immunol; 1992; 36(12):1305-16. PubMed ID: 1287405
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of monoclonal antibodies to Pseudomonas aeruginosa type A flagellar antigen.
    Montie TC; Phillips D; Landsperger WJ
    Behring Inst Mitt; 1997 Feb; (98):424-33. PubMed ID: 9382766
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low-density lipoprotein as an opsonin promoting the phagocytosis of Pseudomonas aeruginosa by U937 cells.
    Li Y; Liu Z; Yang J; Liu L; Han R
    J Microbiol; 2019 Aug; 57(8):711-716. PubMed ID: 31089970
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of a human monoclonal antibody to lipopolysaccharides of Pseudomonas aeruginosa serotype 5: a possible candidate as an immunotherapeutic agent for infections with P. aeruginosa.
    Sawada S; Kawamura T; Masuho Y; Tomibe K
    J Infect Dis; 1985 Nov; 152(5):965-70. PubMed ID: 3930629
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.